A. S. Yar Saglam, A. Yilmaz, H. I. Onen, E. Alp, H. Kayhan, and A. Ekmekci, “HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells”, EXCLI J., vol. 15, pp. 246–255, Apr. 2016.